Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 12 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 7, 2016 BAX F 217 $39.82 $8,641 47,779 Direct -0.45% Disposed -39.2% (price as of 2026-10-05)
March 4, 2016 BAX F 215 $39.46 $8,484 47,997 Direct -0.45% Disposed -38.6% (price as of 2026-10-05)
March 3, 2016 BAX F 1,437 $39.33 $56,517 48,212 Direct -2.89% Disposed -38.4% (price as of 2026-10-05)
March 3, 2016 BAX A 89,419 · · 89,419 Direct · Acquired (price as of 2026-10-05)
March 1, 2016 BAX F 844 $39.98 $33,743 49,649 Direct -1.67% Disposed -39.4% (price as of 2026-10-05)
Feb. 16, 2016 BAX A 463 · · 50,566 Direct +0.92% Acquired (price as of 2026-10-05)
Feb. 16, 2016 BAX F 519 $37.41 $19,416 50,047 Direct -1.03% Disposed -35.3% (price as of 2026-10-05)
Feb. 16, 2016 BAX A 355 · · 50,402 Direct +0.71% Acquired (price as of 2026-10-05)
Aug. 11, 2015 BAX A 108 · · 49,633 Direct +0.22% Acquired (price as of 2026-10-05)
Aug. 11, 2015 BAX A 110 · · 49,743 Direct +0.22% Acquired (price as of 2026-10-05)
July 1, 2015 BAX J 47,458 · · 102,829 Direct +85.71% Acquired (price as of 2026-10-05)
July 1, 2015 BAX J 6,311 · · 48,948 Direct +14.80% Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 3, 2016 BAX Stock Option (Right to Buy) Common Stock, $1 par value (89,419) $39.33 March 3, 2026 89,419 Acquired
July 1, 2015 BAX Stock Option (Right to Buy) Common Stock, par value $1.00 per share (47,458) · March 3, 2025 47,458 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 11 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
July 2, 2015 BAX Common Stock, $1 par value 42,637 Direct
July 2, 2015 BAX Common Stock, $1 par value 777 Indirect
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (8,450) 8,450 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (6,900) 6,900 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (7,800) 7,800 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (11,119) 11,119 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (14,330) 14,330 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (19,688) 19,688 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (20,609) 20,609 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (21,903) 21,903 Direct
July 2, 2015 BAX Stock Option (Right to Buy)→ Common Stock, $1 par value (55,371) 55,371 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BAX

President, Renal
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2016 $204,074 · · · · $550,179 $2,645,007 $4,560,180

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.